Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

APRE

Aprea Therapeutics Inc

May 22 • 04:00PM ET

0.9500

+0.0200 2.15 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: SLS BLRX APVO CUE IMNN

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.54	Insider Own	11.80%	Shs Outstand	11.98M	Perf Week	2.14%
Market Cap	11.76M	Forward P/E	-	EPS next Y	-0.65	Insider Trans	4.30%	Shs Float	10.92M	Perf Month	7.43%
Enterprise Value	-33.98M	PEG	-	EPS next Q	-0.18	Inst Own	38.65%	Short Float	0.94%	Perf Quarter	16.56%
Income	-11.95M	P/S	98.00	EPS this Y	64.64%	Inst Trans	-1.63%	Short Ratio	0.28	Perf Half Y	-20.83%
Sales	0.12M	P/B	0.27	EPS next Y	4.40%	ROA	-34.99%	Short Interest	0.10M	Perf YTD	11.37%
Book/sh	3.51	P/C	0.25	EPS next 5Y	27.68%	ROE	-40.07%	52W High	2.22 -57.21%	Perf Year	-42.77%
Cash/sh	3.75	P/FCF	-	EPS past 3/5Y	88.77% 47.99%	ROIC	-27.92%	52W Low	0.55 73.36%	Perf 3Y	-74.67%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	82.39%	Volatility	12.61% 9.69%	Perf 5Y	-98.88%
Dividend TTM	-	EV/Sales	-283.17	EPS Y/Y TTM	34.76%	Oper. Margin	-10202.01%	ATR (14)	0.09	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	8.92	Sales Y/Y TTM	-90.40%	Profit Margin	-9696.04%	RSI (14)	56.43	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	8.92	EPS Q/Q	65.87%	SMA20	8.45%	Beta	1.52	Target Price	4.30
Payout	-	Debt/Eq	0.00	Sales Q/Q	-100.00%	SMA50	14.64%	Rel Volume	0.51	Prev Close	0.93
Employees	8	LT Debt/Eq	0.00	Earnings	May 13 BMO	SMA200	-12.81%	Avg Volume	369.28K	Price	0.95
IPO	Oct 03, 2019	Option/Short	No / Yes	EPS/Sales Surpr.	-3.53% -	Trades		Volume	189,678	Change	2.15%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)